Clinical Trials

150 enrolled

Plasma cell

Multiple Myeloma

NCT05640999 2026-04-14

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

393 enrolled

Gynecologic

Endometrial Neoplasms

NCT05998642 2026-04-14

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

30 enrolled

Lymphoma, Non-Hodgkin

NCT06880523 2026-04-14

SLIDE-HCC

140 enrolled

Carcinoma, Hepatocellular

NCT01164150 2026-04-13

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

92 enrolled

Gynecologic

Radiation Injuries, Endometrial Neoplasms

NCT01244789 2026-04-13

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

244 enrolled

Gynecologic

Endometrial Neoplasms

NCT02225704 2026-04-13

Radium-223 in Combination With Enzalutamide

45 enrolled

Prostatic Neoplasms

NCT02630693 2026-04-13

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

180 enrolled 14 charts

Breast Neoplasms

NCT03817398 2026-04-13

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

110 enrolled

Leukemia, Myeloid, Chronic-Phase

NCT03869762 2026-04-13

DICE

7 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT05518110 2026-04-13

PaTcH

20 enrolled

Pancreatic Neoplasms

NCT03259035 2026-04-09

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

58 enrolled 12 charts

Phase 2 Enrolling by invitation

Rectal Neoplasms

NCT07062354 2026-04-09

CAPT-HN

50 enrolled

Head and Neck Neoplasms

NCT02595424 2026-04-08

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

67 enrolled 13 charts

Endocrine

Somatostatinoma, Carcinoma, Neuroendocrine

NCT03516279 2026-04-03

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

40 enrolled

Leukemia, Myeloid, Chronic-Phase, Neoplasm, Residual

NCT05289687 2026-04-03

Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

LymphoidOther hematologic neoplasm

20 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05710328 2026-04-03

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT06319027 2026-04-03

GABLE

100 enrolled

CNS

Glioblastoma

NCT07328425 2026-04-03

ISG-TULIPS

20 enrolled

Desmoplastic Small Round Cell Tumor

NCT04438382 2026-04-02

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

1 enrolled 1 chart

Hematologic Neoplasms

NCT06368414 2026-04-02

AsterA

69 enrolled

Leukemia, Myeloid, Chronic-Phase

NCT01898494 2026-04-01

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

519 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT03419234 2026-04-01

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

223 enrolled 14 charts

Prostatic Neoplasms

NCT04221438 2026-04-01

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

3 enrolled 11 charts

Dermatologic

Lymphatic Metastasis, Melanoma

NCT05761171 2026-03-31

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

LymphoidOther hematologic neoplasm

78 enrolled

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06368817 2026-03-31

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

240 enrolled

Diabetes Insipidus, Germinoma

NCT02437851 2026-03-30

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

16 enrolled

Anal Canal Carcinoma, Anus Neoplasms, HIV Infections

NCT06769126 2026-03-30

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

900 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT00428142 2026-03-27

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

95 enrolled

Lymphoma, Lymphoma, Follicular

NCT01396408 2026-03-27

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

137 enrolled

Advanced Rare Tumours

NCT02436707 2026-03-27

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

129 enrolled

Lymphoma

NCT03297606 2026-03-27

CAPTUR

720 enrolled

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT04305548 2026-03-27

ISG-MCS

16 enrolled

Sarcoma

Chondrosarcoma, Mesenchymal

NCT04663997 2026-03-27

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

200 enrolled

Prostatic Neoplasms

NCT05601440 2026-03-27

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

484 enrolled

Breast Neoplasms

NCT06623461 2026-03-27

Canbiome2

128 enrolled

Dermatologic

Melanoma

NCT04383119 2026-03-25

ISG-ARTICLE

Phase 2 Not yet recruiting

100 enrolled

Sarcoma

NCT07203053 2026-03-25

START-lung

48 enrolled

Extensive Stage Lung Small Cell Cancer

NCT07341191 2026-03-25

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Phase 2 Not yet recruiting

40 enrolled

Recurrence, Lymphoma, Mantle-Cell

NCT03410615 2026-03-24

Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

129 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02734537 2026-03-23

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

189 enrolled

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT03493425 2026-03-23

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

82 enrolled

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7

NCT04115631 2026-03-23

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

360 enrolled

Lymphoma, Mantle-Cell

NCT04166318 2026-03-23

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

252 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT04233866 2026-03-23

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

176 enrolled

Pancreatic Neoplasms

NCT04266249 2026-03-23

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

2,175 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT04268550 2026-03-23

Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

124 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04316117 2026-03-23

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

138 enrolled

Breast Neoplasms

NCT04597359 2026-03-23

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

360 enrolled